Locate EECP® Therapy Treatment Centers

Quick Facts

  • Cardiovascular disease (CVD) remains the leading cause of death in the United States, responsible for 840,768 deaths (635,260 cardiac) in 2016. From 2006 to 2016, the US death rate from CVD decreased by 18.6% and from coronary heart disease by 31.8%.

  • In the United States in 2019, coronary events were expected to occur in about 1,055,000 individuals, including 720,000 new and 335,000 recurrent coronary events.

  • The most common symptom of coronary heart disease is angina, also known as chest pain. 10 million people in this country suffer with this crippling pain. According to the Framingham Heart Study, an estimated 500,000 new cases of stable angina occur each year.

  • Coronary artery disease can lead to heart failure, a condition that affects more than 6.5 million Americans. The AHA projects a 46% increase of heart failure prevalence from year 2012 to year 2030, resulting in 8 million or more Americans aged 18 years or older with heart failure.
Source of Quick Facts: Center for Disease Control and Prevention

Chances are that you or someone you know has been diagnosed with coronary artery disease or heart failure. It's frightening when you consider that these are serious conditions for which there are no cures. The good news is these diseases can be managed, and living a full and enjoyable life with the right treatment and healthy lifestyle is possible. EECP therapy has been used extensively to eliminate or improve angina for many patients, particularly those with congestive heart failure. Many patients have reduced the need for nitroglycerin or eliminated use altogether.

Developed by VasoMedical, Inc., EECP therapy has been tested in multicenter, controlled, clinical studies, with positive medical results and a demonstrated quality of life improvement. Enhancing your life's rhythm is at the heart of EECP therapy. With Medicare coverage, there's one more good reason to ask your doctor if EECP therapy is the treatment for you. EECP treatment centers are located around the world.

©2017 Vaso Corporation